Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Authors' Reply to Wang et al., "Comment on 'Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial'".
Okubo Y, Kobayashi S, Murakami M, Sano S, Kikuta N, Ouchi Y, Terui T. Okubo Y, et al. Am J Clin Dermatol. 2024 Nov;25(6):1025-1027. doi: 10.1007/s40257-024-00896-7. Epub 2024 Oct 15. Am J Clin Dermatol. 2024. PMID: 39405017 Free PMC article. No abstract available.
Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
Morita A, Takahashi H, Ozawa K, Imafuku S, Nakama T, Takahashi K, Matsuyama T, Okubo Y, Kitamura S, Matsuda N, Zhao Y, Yokoyama M, Hayashi N, Terui T. Morita A, et al. Among authors: okubo y. J Dermatol. 2019 Sep;46(9):745-751. doi: 10.1111/1346-8138.14997. Epub 2019 Jul 8. J Dermatol. 2019. PMID: 31282051 Free PMC article. Clinical Trial.
Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 results.
Morita A, Takahashi H, Ozawa K, Imafuku S, Takekuni N, Takahashi K, Matsuyama T, Okubo Y, Zhao Y, Kitamura S, Takei K, Yokoyama M, Hayashi N, Terui T. Morita A, et al. Among authors: okubo y. J Dermatol. 2021 Jan;48(1):3-13. doi: 10.1111/1346-8138.15605. Epub 2020 Oct 7. J Dermatol. 2021. PMID: 33029861 Free PMC article. Clinical Trial.
Dietary habits in Japanese patients with palmoplantar pustulosis.
Serizawa N, Okazaki S, Otsuka Y, Koto M, Okabe K, Ito M, Morita T, Hoashi T, Saeki H, Abe N, Mori M, Okubo Y, Yano Y, Mitsui H, Kanda N. Serizawa N, et al. Among authors: okubo y. J Dermatol. 2021 Mar;48(3):366-375. doi: 10.1111/1346-8138.15719. Epub 2021 Jan 6. J Dermatol. 2021. PMID: 33404125
Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S, Kanai Y, Murotani K, Nomura T, Ito K, Ohata C, Yamazaki F, Miyagi T, Takahashi H, Okubo Y, Saeki H, Honma M, Tada Y, Mabuchi T, Higashiyama M, Kobayashi S, Hashimoto Y, Seishima M, Kakuma T. Imafuku S, et al. Among authors: okubo y. J Dermatol Sci. 2021 Mar;101(3):185-193. doi: 10.1016/j.jdermsci.2021.01.002. Epub 2021 Jan 7. J Dermatol Sci. 2021. PMID: 33495058 Free article. Clinical Trial.
1,400 results